First patient dosed in France, expanding the DOMISOL study beyond AustraliaDT‑7012 is being evaluated as monotherapy and in ...

DOJ funds marijuana breathalyzer research; MA cannabis restructuring vote; TX hemp lawsuit; VA gov signs psilocybin bill; MD ...

Oncology biotech Akari Therapeutics has announced a partnership with WuXi XDC, an antibody-drug conjugate (ADC) development ...

If the aches and pains of ongoing osteoarthritis are getting to be too much for you to bear, there may be a new way to find ...

Even with those limitations in mind, there's lots to take away here. One possibility raised by the findings is that dreaming ...

Vivoryon Therapeutics N.V. to Attend Upcoming Investor Conference Halle (Saale) / Munich, Germany, April 9, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clin ...

Preclinical data demonstrate enhanced efficacy of PLT012 in pMMR colorectal cancer models - Findings position CD36 as a promising metabolic checkpoint target in an underserved patient population DOVER ...

Issued claims further strengthen global intellectual property portfolio supporting immune cell modulation platform and expand ...

Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or ...

Pilatus Biosciences to Present New Data Highlighting Sex-Specific Efficacy of CD36-Targeting Antibody in Colorectal Cancer at ...

AX-0810 clinical target engagement data in healthy volunteers on track for this quarter; biliary atresia selected as initial Phase 2 indicationAdditional programs advancing toward the clinic, ...

Myocardial infarction research reveals immune-driven cardiac damage. Learn how targeting NK cells could improve heart ...